Reviva Pharmaceuticals (RVPH) announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock and warrants to purchase common stock in an underwritten public offering. All of the shares of common stock and warrants are being offered by the company. Citizens JMP Securities is acting as the sole bookrunner for the proposed offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVPH:
- Reviva Pharmaceuticals Reports Positive Phase 3 Trial Results
- Reviva announces topline data for OLE portion of Phase 3 RECOVER study
- Largest borrow rate increases among liquid names
- Reviva Pharmaceuticals reports Q3 EPS (25c), consensus (25c)
- Reviva Pharmaceuticals Progresses with Brilaroxazine Study Update